According to WiseGuy Reports, the Oclacitinib Maleate Industry is expected to grow from USD 846.3 Million in 2025 to USD 1,500 Million by 2035 at a CAGR of 5.9%. Growth is being driven by increasing demand for advanced immunology therapies, expanding treatment options for inflammatory disorders, and continued investment in pharmaceutical innovation. Applications spanning atopic dermatitis,...